Hosted on MSN1mon
AstraZeneca's Calquence gains FDA nod for 1L MCL treatmentToday, AstraZeneca PLC (LSE/STO/Nasdaq: LON:AZN), a pharmaceutical giant with a market capitalization of $207.67 billion and impressive gross profit margins of 82.61%, announced that its drug ...
Hosted on MSN1mon
AstraZeneca's Imfinzi on track for EU approval in LS-SCLC treatmentAstraZeneca PLC (LSE/STO/NASDAQ:LON:AZN), a pharmaceutical giant with a market capitalization of $215.44 billion and impressive gross profit margins of 82.61%, has received a recommendation for ...
LONDON, GB / ACCESS Newswire / February 28, 2025 / Physitrack PLC (STO:PTRK) Resilience and Growth: Achieving Positive Cashflow and Momentum in Q4 2024 While Building a Unified Vision for 2025.
Physitrack PLC (STO:PTRK) London, February 13, 2025 - Physitrack is pleased to announce its largest contract to date with a local English public healthcare provider (NHS trust) following a ...
LONDON, UK / ACCESS Newswire / March 7, 2025 / Physitrack PLC (STO:PTRK) has successfully secured a public tender with a Finnish county healthcare system, reinforcing its position as a trusted provide ...
LONDON, UK / ACCESS Newswire / February 28, 2025 / Physitrack PLC (STO:PTRK) London, February 28, 2025 - Physitrack today announces the most significant update to its patient app since its Apple ...
LONDON, GB / ACCESS Newswire / March 4, 2025 / Physitrack PLC (STO:PTRK) London, March 4, 2025 - Physitrack Plc today announced the launch of a major enhancement to its PhysiAssistant app, a mobile so ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results